跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GENRX CEPHALEXIN cefalexin (as monohydrate) 250mg/5mL powder for suspension bottle - TGA Drug Approval Details
Approvals
/
TGA
/
GENRX CEPHALEXIN cefalexin (as monohydrate) 250mg/5mL powder for suspension bottle
Approved
STANDARD
GENRX CEPHALEXIN cefalexin (as monohydrate) 250mg/5mL powder for suspension bottle
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 31, 2025
Approval ID
b9cf8f5f03bb2687
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
b9cf8f5f03bb2687
Product Name
GENRX CEPHALEXIN cefalexin (as monohydrate) 250mg/5mL powder for suspension bottle
Artg Id
98633
Artg Name
GENRX CEPHALEXIN cefalexin (as monohydrate) 250mg/5mL powder for suspension bottle
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2004-01-29
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 31, 2025
Approval ID
b9cf8f5f03bb2687
Type
Standard
Back to TGA Approvals
